JERSEY CITY, N.J., March 26, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Digital Diagnostics Market [https://www.insightaceanalytic.com/report/digital-diagnostics-market/2372] Size, Share & Trends Analysis Report By Application (Cardiology, Oncology, Neurology, Pathology), End-User (Hospitals, Clinical Laboratories), And Product (Hardware And Software), Region, Market Outlook And Industry Analysis 2031"
https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg [https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg]
The Global Digital Diagnostics Market is estimated to reach over USD 6.32 billion by 2031, exhibiting a CAGR of 18.48% during the forecast period.
Digital Diagnostics Market Report Scope:
Report Attribute Specifications Market Size Value In 2023 USD 1.66 Bn Revenue Forecast In 2031 USD 6.32 Bn Growth Rate CAGR CAGR of 18.48% from 2024 to 2031 Quantitative Units Representation of revenue in US$ Bn and CAGR from 2024 to 2031 Historic Year 2019 to 2023 Forecast Year 2024-2031 Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends Segments Covered By Product, Application, and End-User Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2372 [https://www.insightaceanalytic.com/request-sample/2372]
Digital technologies are applied to healthcare diagnostics to change the way diseases are identified, tracked, and treated. This process is known as digital diagnostics. Digital diagnostics offer a more accurate and practical approach to healthcare diagnostics, lowering mistakes, improving accuracy, and enabling early treatments by utilizing data analytics, Al algorithms, and remote patient monitoring.
Digital diagnostics has the potential to enhance test accessibility by overcoming limitations associated with operating hours and personnel availability, which are factors that impede traditional diagnostics.
It can also increase access to diagnostics in low-resource settings, which is more prevalent in high-income, middle-income, and low-income countries, where inadequate infrastructure and medical personnel pose an additional obstacle. Patients may acquire access to superior health information, develop the ability to self-manage their health, ensure adherence to medical treatment, and embrace healthier lifestyles by utilizing digital diagnostics.
The growing use of digital health technologies, growing healthcare expenditures, and the demand for precise and readily available diagnostic solutions are all expected to propel the digital diagnostics market's rise in the upcoming years. Long-standing competitors and recent arrivals can benefit significantly from this market's chances to take advantage of the rising need for cutting-edge diagnostic technology.
List of Prominent Players in the Digital Diagnostics Market:
-- F. Hoffmann-La Roche Ltd
-- Thermo Fisher Scientific Inc.
-- Laboratory Corporation of America Holdings
-- GE Healthcare
-- Siemens Healthineers
-- Medtronic plc
-- Nano-X Imaging Ltd.
-- Koninklijke Philips N.V.
-- Digital Diagnostics Inc.
-- Riverain Technologies
-- VUNO, Inc.
-- AliveCor, Inc.
-- Behold.ai.
-- Brainomix
-- Healthy.io
-- Canon Inc.
Market Dynamics:
Drivers-
Heart disease, diabetes, and cancer are typical chronic illnesses that cause substantial concerns for the world's healthcare systems. Using digital diagnostics to treat chronic diseases has several benefits.
Wearable technology, at-home testing, and remote monitoring can assist with early detection, enabling earlier intervention and reducing the disease burden. Furthermore, electronic diagnostics provide ongoing patient health data monitoring, allowing for more effective sickness treatment and customized drug adjustments.
Challenges:
One major issue is that patients and healthcare professionals need to be made aware of digital diagnostics. Digital diagnostic technology may not be widely used since a number of healthcare professionals may not be aware of its potential and advantages. Similarly, patients might not be aware of the benefits and accessibility of the tools. This ignorance could hinder the use of digital diagnostics and restrict the growth of the sector.
Regional Trends:
The North American digital diagnostics market is expected to register a significant market share in revenue and is projected to develop at a high CAGR soon. The expanding use of cutting-edge technologies, rising investments from both public and private entities, and rising product launches and initiatives by significant market players are all factors contributing to the expansion of the market in the region. For instance, PathAI announced the release of its AISightTM digital pathology image management system (IMS) for pathology laboratories in August 2023.
This will additionally offer effective, comprehensive digital pathology workflows. Besides, Asia Pacific had a substantial share of the market. The rising prices of computer-aided diagnostics in the Asia-Pacific healthcare region are among the causes driving this growth. Growing awareness of these technologies' advantages contributes to developing the digital diagnostics market in Asia-Pacific.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2372 [https://www.insightaceanalytic.com/enquiry-before-buying/2372]
Recent Developments:
-- In Feb 2024, Roche disclosed that it had signed an arrangement with
PathAI. PathAI will collaborate exclusively with Roche Tissue
Diagnostics (RTD) to develop AI-enabled digital pathology algorithms in
the companion diagnostics market, according to the conditions of the
agreement. RTD will collaborate exclusively with PathAI for a set period
as the sole external algorithm development business for AI-powered
companion diagnostics while keeping the opportunity to create its own
algorithms for companion diagnostics. PathAI will retain the freedom to
develop algorithms outside of companion diagnostics.
-- In May 2022: In its most recent round of funding, the MedTech startup
TestCard raised $10 million, which it will broadly use to expand the
market for its current product line and introduce new offerings,
including flu, pregnancy, CKD, and diabetes tests.
-- In February 2022: In order to enable customers to request tests and
potentially collect samples from home, Labcorp introduced Labcorp
OnDemand, an online platform. The best diagnostic tests will be more
easily accessible to people due to this platform.
Segmentation of Digital Diagnostics Market-
By Product-
-- Hardware
-- Software
By Application-
-- Cardiology
-- Oncology
-- Neurology
-- Pathology
-- Others
By End-User-
-- Hospitals
-- Clinical Laboratories
-- Others
By Region-
North America-
-- The US
-- Canada
-- Mexico
Europe-
-- Germany
-- The UK
-- France
-- Italy
-- Spain
-- Rest of Europe
Asia-Pacific-
-- China
-- Japan
-- India
-- South Korea
-- Southeast Asia
-- Rest of Asia Pacific
Latin America-
-- Brazil
-- Argentina
-- Rest of Latin America
Middle East & Africa-
-- GCC Countries
-- South Africa
-- Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/2372 [https://www.insightaceanalytic.com/customisation/2372]
Why should buy this report:
-- To receive a comprehensive analysis of the prospects for global Digital
Diagnostics market
-- To receive industry overview and future trends of global Digital
Diagnostics market
-- To analyze the Digital Diagnostics market drivers and challenges
-- To get information on the Digital Diagnostics market size value (US$ Mn)
forecast till 2031
-- Major Investments, Mergers & Acquisition in global Digital Diagnostics
market industry
Other Related Reports Published by InsightAce Analytic:
AI-Based Digital Pathology Solutions Market [https://www.insightaceanalytic.com/report/global-ai-based-digital-pathology-solutions-market/1492]
Smart or AI In-Vitro Diagnostics Market [https://www.insightaceanalytic.com/report/ai-in-vitro-diagnostics-market/1773]
Virtual Diagnostic Market [https://www.insightaceanalytic.com/report/global-virtual-diagnostic-market/1131]
Digital Health Market [https://www.insightaceanalytic.com/report/digital-health-market/1596]
Cardiac AI Monitoring and Diagnostics Market [https://www.insightaceanalytic.com/report/cardiac-ai-monitoring-and-diagnostics-market-/1952]
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact US:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com [mailto:info@insightaceanalytic.com?subject=openPR.com%20contact]
Site Visit: www.insightaceanalytic.com [https://www.insightaceanalytic.com/]
Follow Us on LinkedIn @ bit.ly/2tBXsgS [https://www.linkedin.com/company/insightace-analytic-pvt-ltd/]
Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg [https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg]
View original content:https://www.prnewswire.co.uk/news-releases/digital-diagnostics-market-to-reach-over-usd-6-32-bn-by-the-year-2031---exclusive-report-by-insightace-analytic-302099342.html [https://www.prnewswire.co.uk/news-releases/digital-diagnostics-market-to-reach-over-usd-6-32-bn-by-the-year-2031---exclusive-report-by-insightace-analytic-302099342.html]
Photo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg InsightAce Analytic Pvt. Ltd
